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Abstract
Background: The clinical spectrum of anti-glutamic acid decarboxylase (GAD) antibody-associated neurologic syndromes is expanding, with focal, generalized,
and atypical forms.
Case Report: We describe a 59-year-old female showing continuous right lower limb myoclonus and mild encephalopathy. These symptoms started 2 weeks prior
to evaluation. The patient had great improvement with intravenous steroids. An autoantibody panel was positive for anti-GAD.
Discussion: Various clinical manifestations, including myoclonus, may relate to anti-GAD antibodies. The treatment options available include symptomatic drugs,
intravenous immunoglobulin, steroids, and other immunosuppressant agents.
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Introduction
We present a 59-year-old female with continuous involuntary move-
ments of her right leg. Mild bradyphrenia was also present. The
symptoms started 2 weeks prior to evaluation.
Case report
The patient had a diagnosis of epilepsy 5 years previously. The
manifestations were different from the current right leg symptoms.
During the seizures, she had clonic movements of the left hand,
left cephalic version, with further generalization. The seizures were
partially controlled with carbamazepine 800 mg/day (one seizure every
3 months). However, 1 month before she was admitted to hospital,
she had four seizures within the same day, with full recovery on the
following day.
The patient’s mild bradyphrenia consisted of slowness of thinking
and impaired attention, characterized by the need to repeat the same
command several times. Patient’s orientation in time and space was
normal.
Physical examination at rest showed spontaneous, continuous,
irregular, low amplitude, involuntary movements limited to the right
leg, suggestive of myoclonic jerks (Video 1 – Segment 1). The jerks were
restricted to the proximal and distal right lower limb. The amplitude and
frequency of movements worsened with action but improved during
sleep. Stimulus sensitivity was apparently absent, but difficult to assess
because of the patient’s continuous jerks. Deep tendon reflexes were
normal. Rapid dorsiflexion of the right foot did not induce or exacerbate
the involuntary movement. There were no painful spasms, startle, fixed
postures, axial, or limb stiffness. The movements did not improve with
valproate 2,500 mg/day and diazepam 40 mg/day.
During the episode, the electromyography (EMG) recorded with
needle electrodes showed spontaneous and synchronous activation
of right vastus lateralis and biceps femoralis. The burst duration was
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30 ms, at a frequency of about 8 Hz, suggestive of myoclonus,
in accordance with clinical observation. Electroencephalography
(EEG), performed two times during the myoclonic jerks, showed mild
disorganization of background activity, with 8 Hz alpha waves, but no
paroxysms or focal slow waves. Back-averaging was not performed due
to technical issues. EEG was compatible with mild encephalopathy.
Brain and spinal magnetic resonance imaging showed non-specific
mild T2 hyperintensities in the deep cerebral white matter and mild
vertebral degenerative changes, respectively. Right and left tibial
nerve somatosensory evoked potential (SSEP) was normal. Cerebro-
spinal fluid (CSF) revealed 20 white cells/mm3, 70% lymphocytes,
14 mg/dL protein, and 61 mg/dL glucose. She had no infectious
stigma, and herpes and CMV serology were negative, bacterial, fungal,
and tuberculosis cultures were also negative. Whole-body positron
emission tomography/computed tomography scan was normal. Serum
and CSF autoantibody panel was positive for anti-glutamic acid
decarboxylase 65 (anti-GAD) antibodies, with strong reactivity in a
tissue-based assay and immunoblotting. Although this test can also be
interpreted by a qualitative analysis, the quantitative measure would
have been more reliable but was not available.1 Antibodies to NMDAR,
LGI1, GABAR, GlyR, AMPAR, and CASPR2 were negative. The
patient’s fasting blood glucose level was within normal limits.
Before the result of the autoantibody panel, the patient was pulsed with
5 g of intravenous methylprednisolone (1 g per day), with a great improve-
ment in both motor and cognitive symptoms (Video 1 – Segment 2). Our
diagnosis was steroid-responsive anti-GAD-related limb myoclonus.
Video 1. Segment 1. Before Treatment. Spontaneous, continuous, irregular, brief, involuntary movements restricted to the right lower limb, suggestive of
myoclonic jerks, that worsen in amplitude and frequency with action. There is no rigidity or stimulus sensitivity. Gait is impaired by the involuntary movements.
Segment 2. After Treatment – 1-Month Follow-up. Intravenous methylprednisolone pulse therapy improved symptoms. Involuntary movements are no
longer observed. Gait is markedly improved.
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Discussion
A similar case has previously been reported, but myoclonus was seen
on both legs and there was no associated encephalopathic features.2
A ‘‘jerking stiff person syndrome’’ has already been described, but the
patient had additional axial rigidity and stimulus-sensitive multifocal
myoclonus.3 The myoclonus of the present case was characterized by
brief (30 ms) duration, which indicates cortical myoclonus.
Cortical myoclonus may be either epileptic or non-epileptic. Contin-
uous cortical epileptic myoclonus may reflect epilepsia partialis continua.4
However, SSEP was normal, which does not further support the hypo-
thesis of cortical myoclonus.4,5 Spinal myoclonus might be another
possible origin, as it is characterized by variable stimulus sensitivity, no
SSEP enlarged responses, and no cortical spikes or sharp waves on
EEG. EMG in spinal myoclonus commonly reveals synchronous acti-
vation of the affected muscle.6 However, the classical duration range of
spinal bursts is 50–500 ms,6 mostly over 100 ms.5 Also, the typical
frequency is in the low range of 0.5–3 Hz.6 By contrast, our patient’s
burst duration was around 30 ms and the frequency was 8 Hz.
The patient’s previous epileptic syndrome could have been an anti-
GAD-related epilepsy.2 This previous epilepsy, in association with
EEG encephalopathy at the time of examination, along with EMG
short-duration and high-frequency bursts (30 ms and 8 Hz), supports
the hypothesis of cortical myoclonus. We think that a cortical origin
of myoclonus was the most likely in our patient. However, the level of
the myoclonus generator could not be definitely ascertained due to
several technical limitations. Notably, jerk-locked back-averaging was
not performed.
The patient’s first clinical presentation was responsive to anti-
epileptic drugs (AEDs). The second, 5 years later, was resistant to
AEDs, but steroid responsive. Differences in responsiveness may be
attributed to different cortical foci.
The anti-GAD antibody is found in various neurological syn-
dromes, including stiff person syndrome (SPS), stiff limb syndrome
(SLS), progressive encephalomyelitis with rigidity and myoclonus
(PERM), opsoclonus–myoclonus, cerebellar ataxia, and autoimmune
epilepsy.7 SPS, SLS, and PERM are part of the stiff person spectrum
disorders (SPSDs), a broad and expanding clinical spectrum.8 SPSD
can be linked with various antibodies other than anti-GAD.8
Anti-GAD antibody-associated neurologic syndromes are not
strongly associated with cancer. Comprehensive investigation for
tumors is not usually indicated.6 However, a study from a large
database of 121 patients with anti-GAD-related syndromes identi-
fied 15 (12%) patients with tumors, such as lung cancer and thymic
neoplasms.6 The clinical presentations were not always those
typically observed in anti-GAD antibodies, such as limbic encephalitis.6
Thus, the atypical features from the present case prompted screen-
ing for cancer.
The mild encephalopathy and associated pleocytosis may suggest
a PERM-related disorder. However, classical features of PERM were
missing, such as dysautonomia, prominent brainstem involvement,
rigidity, and generalized myoclonus.8 The current case may belong to
SPSDs. SPSDs comprise focal variants, atypical forms, and generalized
phenotypes.10 SPSD is an expanding concept.10 However, there was no
clinical stiffness or related neurophysiological findings. In our opinion,
it is thus not appropriate to classify this case under the umbrella of
SPSDs. Our final diagnosis was an anti-GAD antibody-associated
neurologic syndrome presenting with limb myoclonus.
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